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Abstract
Background: Neck circumference (NC) has been previously related to cardiometabolic risk factors. In this study we
examined the association between NC and early stage atherosclerosis in Chinese adults.
Methods: The study samples were from a community-based health examination survey in central China. In total
2,318 men and women (18-64 y) were included in the final analyses. Carotid radial pulse wave velocity (crPWV),
carotid femoral PWV (cfPWV), carotid artery dorsalis pedis PWV (cdPWV) and NC were measured.
Results: After adjustment for age, sex, lipids, glucose, blood pressure, heart rate, body mass index (BMI), high NC
was significantly associated with an increasing trend of cfPWV, cdPWV and crPWV (P = 0.001, 0.049, and 0.038;
respectively). In addition, we found significant interaction between hypertension status and NC level in relation to
cfPWV, adjusted for age, sex, BMI, fasting glucose, lipids and heart rate(P for interaction =0.034). The associations
between NC and cfPWV were significant (P= 0.02) among those with hypertension, but not significant among
those without hypertension.
Conclusions: Our data showed that high NC was associated with an increased risk of early stage atherosclerosis in
Chinese adults, independent of other metabolic risk factors. Hypertension might modify the association between
NC and cfPWV.
Keywords: Neck circumference, Early stage atherosclerosis, Pulse wave velocity
Background
Neck circumference (NC) was recently associated with
various cardiovascular risk factors such as insulin resist-
ance and biochemical components of metabolic syndrome
such as fasting glucose, fasting triglycerides, and blood
pressure, independent of body mass index (BMI) and
waist circumference [1-4]. However, few studies have
assessed the relation between NC and early stage athero-
sclerosis in Chinese adults [5].
Aortic stiffness is an established marker for early
stage atherosclerosis. The recent European Society of
Hypertension/European Society of Cardiology guidelines
for management of arterial hypertension suggested
measurement of pulse wave velocity (PWV) as a tool
for assessment of subclinical atherosclerosis [6]. PWV
is a gold standard for assessing arterial stiffness, and
has been widely used as an indicator for early-staged
atherosclerosis [7-10]. PWV measured at different sites
may reflect the atherosclerotic alterations at central
(e.g. carotid femoral pulse wave velocity (cfPWV)) or
peripheral arteries (e.g. carotid artery dorsalis pedis
pulse wave velocity (cdPWV) and carotid radial pulse
wave velocity (crPWV)). cfPWV is recognized as the
“gold standard” parameter for the evaluation of arterial
stiffness and has had a wide biomedical application
[11,12]. The analysis of the peripheral pulse wave
(cdPWV and crPWV) can provide parameters with dif-
ferent meanings in the arterial dynamics, some already
used to assess the arterial stiffness [13,14].
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gate the relationship between NC and PWV measures
for peripheral and central arterial stiffness in a large
Chinese population.
Methods
Study population
In the cardiometabolic risk in Chinese (CRC) study, we
performed a community-based health examination survey
for 6,431 individuals (18-93y) who were randomly selected
from residents living in the urban area of Xuzhou, China,
in 2009. The details of this study have been presented
elsewhere [3,15-18]. All subjects underwent a complete
medical examination, a clinical consultation, and blood
laboratory tests. All individuals provided details of their
demographic, medical history, and use of medication at
the time of their clinical consultation. We excluded
people who did not undergo PWV determination or
omitted blood sampling, and subjects with goiter and
other neck masses and deformity. In total, 2,318 sub-
jects were included in the final analyses. There was no
significant difference in the clinical characteristics be-
tween the participants of the present analysis and those
who were not included. The protocol and informed
consent document were approved by the ethics commit-
tee of the Central Hospital of Xuzhou. All patients gave
written informed consent.
Anthropometric measures
Neck Circumference (cm) was measured with head erect
and eyes facing forward, horizontally at the upper mar-
gin of the laryngeal prominence with a flexible tape.
Body weight was measured in light clothing to the near-
est 0.1 kg and height to the nearest 0.5 cm. Height and
body weight were measured with participants standing
without shoes and heavy outer garments. Waist circum-
ference was measured at the minimum abdominal girth
to the nearest 0.1 cm. BMI was calculated as weight (in
kilograms) divided by height (in meters) squared. Blood
pressure (BP) was measured after the subject had rested
for at least 5 minutes with a mercury manometer by doc-
tors. Three measurements, 60 seconds apart, were taken.
The mean of the three measurements was used for ana-
lysis. Hypertension was defined as SBP≥140 mmHg and
DBP≥90 mmHg, or the use of antihypertensive medica-
tion, according to the seventh report of the Joint National
Committee on Prevention, Detection, Evaluation and
Treatment of High Blood Pressure (JNC-7).
Assessment of biomarkers
Venous blood sample was drawn from all subjects after
an overnight fast (10 h). The blood was transferred into
glass tubes and allowed to clot at room temperature.
Immediately following clotting serum was separated by
centrifugation for 15 min at 3,000 rpm. Blood samples
were drawn at 120 minutes after the glucose or carbo-
hydrate load. Plasma glucose was measured using the
hexokinase glucose-6-phosphate dehydrogenase method
(Type 7600; Hitachi Ltd, Tokyo, Japan). The levels of
total cholesterol(TC), triglyceride(TG), high-density
lipoprotein cholesterol(HDL-C), low-density lipoprotein
cholesterol(LDL-C) were determined enzymatically using
an autoanalyzer (Type 7600; Hitachi Ltd., Tokyo, Japan).
Fasting insulin was measured by a radioimmunoassay
ethod (Pharmacia, Uppsala, Sweden). HbA1c was mea-
sured using high performance liquid chromatography
(HPLC; HLC-723G7 hemoglobin HPLC ana-lyzer, Tosoh
Corp.) according to the standardized method. The 1999
World Health Organization diagnostic criteria were used to
diagnose diabetes. Individuals diagnosed by a physician and
on antidiabetic medications (self-reported) and/or those
who had fasting glucose ≥126 mg/dl (≥7 mmol/L) and/or
2-hr post-glucose value≥ 199.8 mg/dl (≥11.1 mmol/L).
National Cholesterol Education Programme (NCEP)
guidelines were used for definition of dyslipidemia as
follows [19]: Hypercholesterolemia: serum cholesterol
levels≥200 mg/dl (≥5.2 mmol/l). Hypertriglyceridemia:
serum TG levels ≥150 mg/dl (≥1.7 mmol/l). Low HDL chol-
esterol: HDL cholesterol levels <40 mg/dl(<1.04 mmol/l)
for men and <50 mg/dl (<1.3 mmol/l) for women. High
LDL cholesterol: LDL cholesterol levels≥ 130 mg/dl
(≥3.4 mmol/l).
Assessment of PWVs
Before the study started, sonographers were trained for
PWV measurements. All measurements were performed
in a quiet room with controlled ambient temperature.
The cfPWV was measured in the supine position after
5 min of bed rest using an automatic waveform analyzer
(Complior System, Artech-Medical corp. French), the
pulse wave of the carotid and femoral arteries was ana-
lyzed, estimating the delay with respect to the ECG wave
and calculating the PWV. cdPWV and crPWV were ob-
tained in a similar way, with the pulse wave being mea-
sured simultaneously in the right radial, dorsum of foot
and right carotid arteries. 16 consecutive electrocardio-
g r a mg a t e dw a v e f o r m sw e r eo b t a i n e da n dr e m o v e dt h e
three maximum and three minimum. We averaged 10
waveforms. PWV was based on the distance/time ratio
(meters/second), was calculated as the path length di-
vided by the transit time and expressed as m/s [13]. The
operators’ concordance in pulse wave measurements
ranged from 0.85 to 0.92.
Statistical analyses
The relations between NC levels (in quintiles) and PWVs
were examined using general linear regression models,
adjusting for covariates including age, sex, BMI, heart
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teractions between NC and other cardiometabolic risk
factors were assessed by introduction of cross-product
term in the regression models. All the reported P values
are two tailed. Variables with P values of<0.05 were con-
sidered statistically significant. Data management and stat-
istical analysis were conducted using SAS statistical
software (version 9.1; SAS Institute, Inc., Cary, NC, USA).
Results
The study population was represented by 65.3% of men,
with average age of 46.5 years. Table 1 shows the charac-
teristics of the study participants according to NC levels
(in quintiles). BMI, waist circumference, BP, and plasma
levels of glucose, TC, TG and LDL-C showed significant
differences across NC groups.
Table 2 displays the associations between PWVs and
NC. After adjustment for age and sex, high levels of NC
were significantly associated with an increasing trend of
cfPWV, crPWV and cdPWV in a dose-dependent pattern.
Further adjustment for lipids, glucose, systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), HR, and BMI
did not significantly change the associations.
Then we examined whether cardiometabolic risk factors
modified the relation between NC and cfPWVs (Table 3).
Age, sex, BMI, HR, diabetes status, and dyslipidemia did
not significantly interact with NC in relation to cfPWV.
We found significant interaction between hypertension
status and NC level in relation to cfPWV, adjusted for
age, sex, BMI, fasting glucose, lipids and HR (P for inter-
action=0.034). The associations between NC and cfPWV
were significant (P=0.02) among the participants with
hypertension, but not among those with non-hypertension
(Figure 1).
Discussion
In this study, we found that high NC was significantly
associated increasing PWV measures for both peripheral
and central arterial stiffness in Chinese adults. The asso-
ciations were independent of other adiposity measures
such as BMI and waist circumference, as well as trad-
itional cardiometabolic risk factors. Moreover, we found
that blood pressure modified the relation between NC
and cfPWV.
As a risk factor for cardiovascular disease [20], aortic
stiffness is recognized as an important marker for early
artherosclerosis [21,22]. cfPWV is considered to be the
gold standard method for assessing aortic stiffness [23,24],
and has been associated with cardiovascular outcomes
such as myocardial infarction, heart failure, and mortality
[7,25]. Individual metabolic syndrome components have
been related with subclinical atherosclerosis in previous
studies, for example, central obesity showed strong correl-
ation with carotid atherosclerosis [26-29]. Our findings
Table 1 Characteristics of participants by NC in quintiles
Variables NC (in quintiles)
Q1 (women< 31,
men<36)
Q2 (women31-32,
men36-37)
Q3 (women32.1-33,
men37.1-38)
Q4 (women33.1-34,
men38.1-40)
Q5 (women>34.1,
men> 40)
P for
trend
N 670 393 381 494 380
Age, years 46.4±10.1 43.6± 9.1 45.8±9.5 46.9±9.4 46.8± 8.8 0.498
BMI, kg/m
2 22.5±2.4 24.0± 2.2 25.0±2.2 26.1±2.3 27.9± 3.0 <0.0001
WC, cm 80.4±7.7 84.6± 7.1 87.6±7.7 91.7±7.2 96.1± 9.0 <0.0001
Systolic blood pressure, mmHg 121.1± 15.2 124.4±15.2 124.2±15.8 128.3± 16.3 130.7±15.6 <0.0001
Diastolic blood pressure, mmHg 77.1±11.1 77.9± 10.7 80.0±11.4 82.6±11.6 83.9± 11.4 <0.0001
Fasting glucose, mmol/L 5.2± 1.5 5.1±0.9 5.3± 1.1 5.3± 1.1 5.5±1.4 0.001
Totalcholesterol, mmol/l 4.9± 0.9 5.1±0.9 5.1± 0.9 5.1± 0.9 5.2±1.0 0.0001
Triglyceride, mmol/L 1.4± 1.2 1.8±1.9 1.8± 1.5 2.1± 1.7 2.3±2.6 <0.0001
LDL-C, mmol/L 2.9± 0.8 3.0±0.8 3.0± 0.8 3.1± 0.8 3.1±0.8 <0.0001
HDL-C, mmol/L 1.3± 0.3 1.3±0.3 1.2± 0.3 1.1± 0.3 1.1±0.3 0.0037
Hypertention 19.7% 20.1% 22.8% 27.7% 31.8% <0.0001
Diabetes 6.1% 7.6% 10.0% 10.9% 12.6% 0.0062
High LDL 11.2% 12.0% 13.9% 18.6% 18.9% <0.0001
Low HDL 4.2% 4.8% 5.5% 5.9% 6.3% 0.0159
Hypertriglyceridemia 9.9% 11.2% 12.1% 15.8% 17.9% <0.0001
Hypercholesterolemia 10.9% 12.7% 13.4% 17.6% 18.8% 0.0317
Abbreviations: WC waist circumference, HDL-C high density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol. Data are age and sex adjusted;
Mean ± standard deviation; Linear regression model was used to test trend for continuous variables.
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[30] found significant association between NC and carotid
intima thickness. Zhou et al. [31] found that NC was
significantly associated with cardiometabolic risk factors
independent of the classical anthropometric indices in
adults Chinese.
The precise mechanisms underlying the associations
between NC and arterial stiffening remain not fully under-
stood. In our study, adjustment for various cardiometa-
bolic risk factors, such as age, sex, BMI, fasting glucose,
lipids, BP and HR, did not change the associations be-
tween NC and PWVs, suggesting that the effects of NC
Table 2 Associations of NC with central and peripheral arterial stiffness
NC (in quintiles)
Q1 Q2 Q3 Q4 Q5 P for trend
cfpwv 10.65(1.84) 10.69(1.75) 10.62(1.83) 10.99(2.00) 11.01(1.78) 0.001
cfpwv 9.62(1.47) 9.67(1.53) 9.75(1.53) 9.96(1.40) 10.02(1.51) 0.049
cfpwv 10.44(1.53) 10.41(1.43) 10.55(1.62) 10.67(1.55) 10.61(1.50) 0.038
PWVs are presented as mean (standard deviation), adjusted sex, age, TC, TG, HDL, LDL, glucose, SBP, DBP, HR, BMI.
Table 3 Stratified associations between NC and cfPWV by cardiometabolic risk factors
Q1 Q2 Q3 Q4 Q5 p for trend p for interaction
Sex
0 9.87±1.40 10.07± 1.79 9.89±1.25 10.46± 1.93 10.38± 1.50 0.024 0.387
1 10.90± 1.89 10.94± 1.67 10.91± 1.94 11.09± 2.00 11.28± 1.83 0.003
Age
<40 9.96±1.28 10.23± 1.29 10.26± 1.37 10.30± 1.33 10.49± 1.28 0.009 0.506
40 to 60 10.45± 1.33 10.28± 1.33 10.27± 1.29 10.72± 1.42 10.76± 1.49 0.048
>60 11.59± 2.39 11.61± 2.15 11.43± 2.45 11.83± 2.59 11.61± 2.14 0.183
BMI
<28 10.65± 1.84 10.69± 1.76 10.62± 1.84 11.00± 2.06 10.85± 1.57 0.034 0.230
>=28 10.39± 1.86 10.78± 1.47 10.74± 1.74 10.99± 1.73 11.18± 1.96 0.211
HR
< = 65 10.36± 1.56 10.28± 1.46 10.28± 1.26 10.70± 1.66 10.56± 1.35 0.030 0.868
>65, < = 75 10.59± 1.83 10.69± 1.83 10.50± 1.81 11.02± 1.90 10.99± 1.65 0.008
>75 11.12± 2.11 11.15± 1.85 11.13± 2.23 11.33± 2.40 11.40± 2.09 0.202
Diabetes
No 10.52± 1.70 10.59± 1.70 10.44± 1.57 10.81± 1.75 10.87± 1.68 0.131 0.316
Yes 12.25± 2.63 12.13± 1.83 12.31± 2.85 12.47± 3.05 11.95± 2.17 0.282
Hypercholesterolemia
No 10.42± 1.80 10.47± 1.60 10.54± 1.87 10.80± 1.89 10.90± 1.74 0.018 0.982
Yes 10.83± 1.89 10.88± 1.87 11.08± 1.75 11.16± 2.11 11.23± 1.82 0.010
Hypertriglyceridemia
No 10.51± 1.82 10.56± 1.86 10.70± 1.89 10.87± 2.04 10.91± 1.62 0.013 0.996
Yes 10.98± 1.87 11.03± 1.41 11.08± 1.64 11.13± 1.95 11.31± 1.89 0.017
High LDL
No 10.51± 1.78 10.58± 1.63 10.61± 1.96 10.93± 1.95 11.00± 1.83 0.021 0.890
Yes 10.66± 2.01 10.83± 1.94 11.01± 1.49 11.06± 2.08 11.14± 1.70 0.006
Low HDL
No 10.70± 1.83 10.81± 1.89 10.53± 1.95 11.03± 2.18 10.97± 1.86 0.113 0.074
Yes 10.47± 1.85 10.53± 1.34 10.76± 1.63 10.95± 1.72 11.06± 1.70 <0.001
Analyses were adjusted for age, sex, BMI, glucose, total cholesterol, triglyceride, HDL-C, LDL-C, blood pressure, heart rate, diabetes, dyslipidemia but not the strata
variable. cfPWV is presented as mean ± standard deviation.
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mechanisms have been proposed to link NC with develop-
ment of atherosclerosis. Upper-body subcutaneous fat has
been demonstrated to be responsible for the majority of
systemic free fatty acid release, particularly in obese indi-
viduals [32]. It has been shown that elevated concentration
of free fatty acid increased oxidative stress [33] and
provoked vascular endothelial injury [34]. In addition,
NC is an important predictor for obstructive sleep
apnea (OSA), and OSA has been associated with arter-
ial stiffening [35,36].
Intriguingly, we found that the adverse effects of NC
on central arterial stiffness appeared to be more evident
in people with hypertension than those with normal
blood pressure. Notably, on average cfPWV was much
higher and its variance was larger in individuals with
hypertension than those without hypertension (Figure 1);
it is therefore not surprising a null association was ob-
served between NC and cfPWV in subjects without
hypertension because of the narrow variance. Laakso
[37] reported that a higher NC was associated with
about 3-fold increased risk of hypertension after adjust-
ment for BMI. However, our data indicate that the asso-
ciations between NC and cfPWV were independent of
blood pressure, suggesting other mechanisms might be
involved to explain the stronger associations in patients
with hypertension. High NC has been related to various
metabolic changes. We assume that certain changes
may interact with hypertension in promoting athero-
sclerosis. For example, in a previous prospective study,
it was found that inflammation-mediated proatherogenic
activation led to significant increase of arterial stiffness in
essential hypertensive patients [38]. Our findings suggest
that high NC levels may play a more important role in
arterial stiffness along with hypertension. This finding
might have important clinical implications for preven-
tion and intervention of cardiovascular risk at early
stage. Further investigations are warranted to explore
the potential mechanisms.
To our knowledge, the present study is among the first
to assess the associations of NC and markers of early stage
atherosclerosis in apparently healthy Chinese adults. How-
ever, several limitations of this study warrant consider-
ation. First, the study is cross-sectional, thus we could not
define a causal association between NC and PWVs. Sec-
ond, neck circumference is used to represent upperbody
subcutaneous fat, we did not perform radiographic mea-
sures to quantify this depot of fat directly. Potential
confounding might exist as risk factors such as cigarette
smoking was not measured in our study. Intima-Media
Thickness and ankle-brachial-index are complementary
parameters to evaluate the severity of early atheroscler-
osis [39,40]. However these markers were not measured
in our study. Finally, the study was performed in a
Chinese population, further studies in other populations
of different ethnicities are warranted to verify our
findings.
Conclusions
In summary, we found that high NC was associated with
markers of an increased risk of early stage atherosclerosis
in Chinese adults, independent of other metabolic risk
factors. Blood pressure might modify the associations.
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